About this trial
The purpose of this study is to assess effects of intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (dlPFC) and dorsomedial prefrontal cortex (dmPFC) compared to sham on electrophysiological indices of reward sensitivity and motivated attention in adults with cocaine use disorder.
Eligibility criteria
Qualifiers
non-treatment-seeking adults
meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for current cocaine use disorder of at least moderate severity (≥ 4 symptoms)
have at least 1 positive urine Benzoylecgonine (BE) specimen (≥ 300 ng/mL) during intake
be able to understand the consent form and provide written informed consent
Disqualifiers
current DSM-5 diagnosis for substance use disorder (of at least moderate severity) other than cocaine, marijuana, or nicotine
in the opinion of the principal investigator (PI), the presence of any medical, neurological, psychiatric, or physical condition, disease, or illness that, may: (a) compromise interfere, limit, effect or reduce the subject's ability to complete the study; or (b) adversely impact the safety of the subject or the integrity of the data
Structured Clinical Interview for DSM-5 (SCID-5)
Columbia Suicide Severity Rating Scale (C-SSRS) Screener - Answers YES to Questions 3, 4, 5, or 6
Trial design
Treatments tested in this trial
- TMS to dmPFC
- TMS to dlPFC
- Sham iTBS
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator